TRPV1 and breast cancer: Our results demonstrated that pharmacological blockade of TRPV1 actions using synthetic and natural antagonist and genetic ablation of TRPV1 not only inhibited SN excitation and BCIBP induction but also decreased BC progression in tibiae, and lung metastasis from tibiae.